BioCentury
ARTICLE | Company News

Pharmatest, ValiRx deal

January 9, 2012 8:00 AM UTC

ValiRx's ValiFinn Oy subsidiary acquired Pharmatest's biomarkers business unit, along with five families of patents and patent applications and related IP. Pharmatest received a €75,000 ($97,080) paym...